Back to: products

Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

PrintEmail
Mar 2022 - 139 Pages - From $2,900
(Excel Data Sheet: $1,500)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Asia Pacific pharmaceutical contract research organization (CRO) market will grow by 11.3% annually with a total addressable market cap of $ 212.8 billion over 2022-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 66 tables and 47 figures, this 139-page report “Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services
Based on Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Asia Pacific Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of Asia Pacific Market by Service 44
3.1 Market Overview by Service 44
3.2 CRO for Pre-clinical Development 46
3.3 CRO for Phase I Trials 47
3.4 CRO for Phase II Trials 48
3.5 CRO for Phase III Trials 49
3.6 CRO for Phase IV Trials 50
3.7 Laboratory Services 51
3.8 Consulting Services 52
3.9 Data Management Services 53
4 Segmentation of Asia Pacific Market by Therapeutic Application 54
4.1 Market Overview by Therapeutic Application 54
4.2 Infectious Diseases 56
4.3 Oncology 57
4.4 Metabolic Disorders 58
4.5 Cardiovascular Disorders 59
4.6 Central Nervous System 60
4.7 Respiratory Disorders 61
4.8 Gastrointestinal Disorders 62
4.9 Other Therapeutic Applications 63
5 Segmentation of Asia Pacific Market by End User 64
5.1 Market Overview by End User 64
5.2 Pharmaceutical & Biopharmaceutical Companies 66
5.3 Medical Device Companies 67
5.4 Academic Institutes 68
6 Asia-Pacific Market 2019-2030 by Country 69
6.1 Overview of Asia-Pacific Market 69
6.2 Japan 72
6.3 China 75
6.4 Australia 77
6.5 India 79
6.6 South Korea 82
6.7 Rest of APAC Region 84
7 Competitive Landscape 86
7.1 Overview of Key Vendors 86
7.2 New Product Launch, Partnership, Investment, and M&A 90
7.3 Company Profiles 91
Charles River Laboratories 91
CMIC Co. Ltd 93
Covance Inc. 95
Hangzhou Tigermed Consulting Co., Ltd. 99
ICON Plc 102
IQVIA Holdings Inc. 105
LSK Global Pharma Service Co., Ltd. 109
Novotech Pty Ltd 111
PAREXEL International Corporation 113
Pharmaceutical Product Development LLC (PPD) 117
PRA Health Sciences Inc. 119
Quanticate Ltd 121
Samsung Bioepis Co., Ltd. 123
SGS SA (SGS Life Sciences) 125
Syneos Health Inc. 128
WuXi AppTec Inc. 131
8 Investing in Asia Pacific Market: Risk Assessment and Management 133
8.1 Risk Evaluation of Asia Pacific Market 133
8.2 Critical Success Factors (CSFs) 136
Related Reports and Products 139

List of Tables:

Table 1. Snapshot of Asia Pacific Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27
Table 4. Worldwide Total Number of Registered Clinical Trials 29
Table 5. World Health Spending by Region, $ bn, 2013-2020 32
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical CRO Market 36
Table 7. Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, $ bn 44
Table 8. Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 54
Table 9. Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, $ bn 64
Table 10. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn 70
Table 11. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn 74
Table 12. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 74
Table 13. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn 74
Table 14. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn 76
Table 15. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 76
Table 16. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn 76
Table 17. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 78
Table 18. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 78
Table 19. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 78
Table 20. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn 81
Table 21. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 81
Table 22. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn 81
Table 23. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn 83
Table 24. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 83
Table 25. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn 83
Table 26. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn 85
Table 27. Breakdown of World Market by Key Vendor, 2020, % 88
Table 28. Charles River Laboratories: Company Snapshot 91
Table 29. Charles River Laboratories: Product Portfolio 92
Table 30. CMIC Co. Ltd.: Company Snapshot 93
Table 31. CMIC Co. Ltd.: Business Segmentation 94
Table 32. CMIC Co. Ltd.: Revenue by Region, 2018, % 94
Table 33. Covance Inc.: Company Snapshot 95
Table 34. Covance Inc.: Product Portfolio 96
Table 35. Covance Inc.: Revenue by Region, 2020, % 97
Table 36. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot 99
Table 37. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation 100
Table 38. ICON Plc: Company Snapshot 102
Table 39. ICON Plc: Business Segmentation 102
Table 40. ICON Plc: Product Portfolio 103
Table 41. ICON Plc: Revenue by Region, 2020, % 103
Table 42. IQVIA Holdings Inc.: Company Snapshot 105
Table 43. IQVIA Holdings Inc.: Business Segmentation 106
Table 44. IQVIA Holdings Inc.: Revenue by Region, 2020, % 106
Table 45. IQVIA Holdings Inc.: Product Portfolio 107
Table 46. LSK Global Pharma Service Co., Ltd.: Company Snapshot 109
Table 47. Novotech Pty Ltd: Company Snapshot 111
Table 48. PAREXEL International Corporation: Company Snapshot 113
Table 49. PAREXEL International Corporation: Business Segmentation 114
Table 50. PAREXEL International Corporation: Revenue by Region, 2018, % 114
Table 51. PAREXEL International Corporation: Product Portfolio 115
Table 52. Pharmaceutical Product Development LLC (PPD): Company Snapshot 117
Table 53. PRA Health Sciences Inc.: Company Snapshot 119
Table 54. PRA Health Sciences Inc.: Business Segmentation 120
Table 55. PRA Health Sciences Inc.: Revenue by Region, 2018, % 120
Table 56. Quanticate Ltd: Company Snapshot 121
Table 57. Samsung Bioepis Co., Ltd.: Company Snapshot 123
Table 58. SGS SA (SGS Life Sciences): Company Snapshot 125
Table 59. SGS SA (SGS Life Sciences): Business Segmentation 126
Table 60. SGS SA (SGS Life Sciences): Revenue by Region, 2018, % 126
Table 61. Syneos Health Inc.: Company Snapshot 128
Table 62. Syneos Health Inc.: Business Segmentation 129
Table 63. Syneos Health Inc.: Revenue by Region, 2018, % 129
Table 64. WuXi AppTec Inc.: Company Snapshot 131
Table 65. Risk Evaluation for Investing in Asia Pacific Market, 2021-2030 134
Table 66. Critical Success Factors and Key Takeaways 137

 

 

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030 17
Figure 5. Asia Pacific Pharmaceutical CRO Market, 2019-2030, $ bn 20
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical CRO Market 25
Figure 8. Leading Causes of Death in the World, 2019-2020, million 30
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 31
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical CRO Market 33
Figure 12. Investment Opportunity Analysis 37
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical CRO Market 40
Figure 14. Breakdown of Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 45
Figure 15. Asia Pacific Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%) 45
Figure 16. Asia Pacific Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 46
Figure 17. Asia Pacific Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 47
Figure 18. Asia Pacific Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 48
Figure 19. Asia Pacific Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 49
Figure 20. Asia Pacific Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 50
Figure 21. Asia Pacific Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 51
Figure 22. Asia Pacific Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 52
Figure 23. Asia Pacific Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 53
Figure 24. Breakdown of Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 55
Figure 25. Asia Pacific Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%) 55
Figure 26. Asia Pacific Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 56
Figure 27. Asia Pacific Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 57
Figure 28. Asia Pacific Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 58
Figure 29. Asia Pacific Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 59
Figure 30. Asia Pacific Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 60
Figure 31. Asia Pacific Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 61
Figure 32. Asia Pacific Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 62
Figure 33. Asia Pacific Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 63
Figure 34. Breakdown of Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 65
Figure 35. Asia Pacific Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%) 65
Figure 36. Asia Pacific Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 66
Figure 37. Asia Pacific Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 67
Figure 38. Asia Pacific Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 68
Figure 39. Breakdown of APAC Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 70
Figure 40. Contribution to APAC 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 71
Figure 41. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn 73
Figure 42. Pharmaceutical CRO Market in China, 2019-2030, $ bn 75
Figure 43. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn 77
Figure 44. Pharmaceutical CRO Market in India, 2019-2030, $ bn 79
Figure 45. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn 82
Figure 46. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn 84
Figure 47. Growth Stage of Asia Pacific Pharmaceutical CRO Industry over the Forecast Period 86

 

Reviews

There are yet no reviews for this product.